COc1ccc(-c2cc(NC(C)=O)c3ncc(-c4cccc(C(F)(F)F)c4)n3c2)c(OC)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?